Follow
Hossein Pakdaman
Hossein Pakdaman
Verified email at sbmu.ac.ir
Title
Cited by
Cited by
Year
Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19
L Simani, M Ramezani, IA Darazam, M Sagharichi, MA Aalipour, ...
Journal of neurovirology 27 (1), 154-159, 2021
1602021
The role of anxiety and cortisol in outcomes of patients with Covid-19
M Ramezani, L Simani, E Karimialavijeh, O Rezaei, M Hajiesmaeili, ...
Basic and clinical neuroscience 11 (2), 179, 2020
812020
Stem cell therapy in Alzheimer’s disease: possible benefits and limiting drawbacks
M Alipour, SM Nabavi, L Arab, M Vosough, H Pakdaman, E Ehsani, ...
Molecular biology reports 46, 1425-1446, 2019
692019
Vitamin D and multiple sclerosis
AA Harandi, AA Harandi, H Pakdaman, MA Sahraian
Iranian journal of neurology 13 (1), 1, 2014
582014
S100 B: A new concept in neurocritical care
O Rezaei, H Pakdaman, K Gharehgozli, L Simani, A Vahedian-Azimi, ...
Iranian journal of neurology 16 (2), 83, 2017
562017
Vitamin d3 concentration correlates with the severity of multiple sclerosis
S Shahbeigi, H Pakdaman, SM Fereshtehnejad, E Nikravesh, N Mirabi, ...
International journal of preventive medicine 4 (5), 585, 2013
482013
Association of serum 25 (OH) vitamin D3 concentration with severity of multiple sclerosis
AA Harandi, S Shahbeigi, H Pakdaman, SM Fereshtehnejad, E Nikravesh, ...
Iranian journal of neurology 11 (2), 54, 2012
482012
Epidemiology of headaches in Tehran urban area: a population-based cross-sectional study in district 8, year 2010
S Shahbeigi, SM Fereshtehnejad, N Mohammadi, MM Golmakani, ...
Neurological Sciences 34, 1157-1166, 2013
452013
The effect of NeuroAiD™(MLC601) on cerebral blood flow velocity in subjects' post brain infarct in the middle cerebral artery territory
RB Shahripour, G Shamsaei, H Pakdaman, N Majdinasab, EM Nejad, ...
European Journal of Internal Medicine 22 (5), 509-513, 2011
412011
Influence of CYP2C9 polymorphism on metabolism of valproate and its hepatotoxin metabolite in Iranian patients
N Amini-Shirazi, MH Ghahremani, R Ahmadkhaniha, A Mandegary, ...
Toxicology Mechanisms and Methods 20 (8), 452-457, 2010
382010
Safety and efficacy of MLC601 in Iranian patients after stroke: a double-blind, placebo-controlled clinical trial
AA Harandi, R Abolfazli, A Hatemian, K Ghragozlee, M Ghaffar-Pour, ...
Stroke research and treatment 2011, 2011
362011
Vagus nerve stimulation in drug-resistant epilepsy: the efficacy and adverse effects in a 5-year follow-up study in Iran
H Pakdaman, A Amini Harandi, M Abbasi, M Karimi, MA Arami, SA Mosavi, ...
Neurological Sciences 37, 1773-1778, 2016
302016
Persian version of frontal assessment battery: Correlations with formal measures of executive functioning and providing normative data for Persian population
S Asaadi, F Ashrafi, M Omidbeigi, Z Nasiri, H Pakdaman, A Amini-Harandi
Iranian Journal of Neurology 15 (1), 16, 2016
292016
Is it time to revise the classification of geographical distribution of multiple sclerosis?
MA Sahraian, H Pakdaman, AA Harandi
Iranian journal of neurology 11 (2), 77, 2012
252012
cis pT231-Tau Drives Neurodegeneration in Bipolar Disorder
R Naserkhaki, S Zamanzadeh, H Baharvand, SM Nabavi, H Pakdaman, ...
ACS Chemical Neuroscience 10 (3), 1214-1221, 2019
242019
Balo’s concentric sclerosis: an update and comprehensive literature review
A Amini Harandi, A Esfandani, H Pakdaman, M Abbasi, MA Sahraian
Reviews in the Neurosciences 29 (8), 873-882, 2018
242018
Comprehensive review on neuro-COVID-19 pathophysiology and clinical consequences
H Jafari Khaljiri, M Jamalkhah, A Amini Harandi, H Pakdaman, M Moradi, ...
Neurotoxicity research 39 (5), 1613-1629, 2021
222021
Effectiveness and safety of MLC601 in the treatment of mild to moderate Alzheimer's disease: a multicenter, randomized controlled trial
H Pakdaman, AA Harandi, H Hatamian, M Tabatabae, ...
Dementia and geriatric cognitive disorders extra 5 (1), 96-106, 2015
222015
The outbreak of methanol intoxication during COVID-19 pandemic: prevalence of brain lesions and its predisposing factors
L Simani, M Ramezani, M Roozbeh, S Shadnia, H Pakdaman
Drug and chemical toxicology 45 (4), 1500-1503, 2022
202022
Biosimilars: opinion of an expert panel in the Middle East
S Bohlega, S Al-Shammri, IA Sharoqi, M Dahdaleh, S Gebeily, J Inshasi, ...
Current medical research and opinion 24 (10), 2897-2903, 2008
202008
The system can't perform the operation now. Try again later.
Articles 1–20